{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:26Z","timestamp":1759104206212,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jneuroim.2020.577231","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:29:11Z","timestamp":1585769351000},"page":"577231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Limbic encephalitis in a neuroscientist: CASPR 2 antibody-associated disease after antigen exposure"],"prefix":"10.1016","volume":"343","author":[{"given":"Bj\u00f6rn","family":"Ryberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Arvidsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"My","family":"Bergkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577231_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","article-title":"The lung as a route to systemic delivery of therapeutic protein and peptides","volume":"2","author":"Agu","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0b013e3182698dc3","article-title":"Autoimmune pain. An emerging concept","volume":"79","author":"Bennet","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0015","first-page":"1","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"0","author":"Binks","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0020","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"278","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577231_bb0030","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577231_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577231_bb0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.vaccine.2007.11.010","article-title":"Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis","volume":"26","author":"Low","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0055","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ana.22674","article-title":"Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol","volume":"71","author":"Meeusen","year":"2012","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577231_bb0060","article-title":"Caspr2 autoantibodies target multiple epitopes","volume":"2","author":"Olsen","year":"2015","journal-title":"Neurol.: Neuroimmun. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577231_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(78)90142-9","article-title":"Multiple specificites of antibrain antibodies in multiple sclerosis and chronic myelopathy","volume":"38","author":"Ryberg","year":"1978","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41423-018-0018-y","article-title":"The long and latent road to autoimmunity","volume":"15","author":"Selmi","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/pri.5.3.16851","article-title":"An underestimated vehicle for transmission of prion diseases?","volume":"5","author":"Stitz","year":"2011","journal-title":"Prion"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"78","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577231_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2020.577231_bb0095","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4049\/jimmunol.119.6.2137","article-title":"In vivo responses to inhaled proteins. I. Quantitative analysis of antigen uptake, fate, and immunogeneity in a rabbit model system","volume":"119","author":"Willoughby","year":"1977","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819304990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819304990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:36:15Z","timestamp":1759048575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819304990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"alternative-id":["S0165572819304990"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577231","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limbic encephalitis in a neuroscientist: CASPR 2 antibody-associated disease after antigen exposure","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577231"}}